Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ROAR (Reduction of Animals in Research) is a specialized contract research organization (CRO) that focuses on providing advanced in vitro alternatives to traditional animal testing. The company leverages cutting-edge organ-on-a-chip technology and complex 3D cell culture models to conduct high-fidelity toxicology and pharmacology studies for the pharmaceutical and biotech industries. By utilizing human-relevant cell systems, ROAR aims to improve the predictive accuracy of preclinical drug development while significantly reducing the ethical and financial burdens associated with animal research. Their services include customized assay development, safety assessment, and efficacy testing across various therapeutic areas.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Reduction of Animals in Research.